| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Undecoylium chloride iodine |
Is a |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Merodicein |
Is a |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Sodium meralein |
Is a |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Mercocresols |
Is a |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Antiinfektiøst middel til huden |
Is a |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| hudsvampemiddel |
Is a |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| antiinfektiøst middel til slimhinder |
Is a |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| undecylensyre og undecylenatsalt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| antiinfektiøst middel til huden |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing sulconazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing terbinafine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing povidone iodine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| forgiftning med antiinfektiøst middel til lokal anvendelse |
Causative agent |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing cetylpyridinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing triclosan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Terbinafine hydrochloride 10 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing naftifine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| antiinfektiøst middel til lokal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing oxychlorosene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing hexachlorophene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing econazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing hexetidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing ichthammol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Ketoconazole [infections] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Ketoconazole 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Miconazole [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing precisely miconazole 25 milligram/1 gram conventional release oral gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Natamycin [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Nystatin [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing precisely nystatin 100000 unit/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Nystatin 500000 unit oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| nystatin GF/LF/SF 100.000 IE/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Terbinafine hydrochloride [1] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Preparations for common vaginal infections |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Econazole nitrate [gynecological use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| econazolnitrat 150 mg/1 % vagitorier + creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing precisely econazole nitrate 150 milligram/1 each conventional release vaginal pessary (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Ketoconazole [gynecological use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Miconazole [genital] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing precisely miconazole nitrate 20 milligram/1 gram conventional release vaginal cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Miconazole nitrate 100 mg vaginal pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| miconazolnitrat 100 mg/2 % vagitorium + creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Natamycin [gynecological use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Nystatin [gynecological use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing precisely nystatin 25000 unit/1 gram conventional release vaginal cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| nystatin 100.000 enheder vagitorium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Vaginal antiseptic preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Povidone-iodine [gynecological use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| povidoniod 200 mg vagitorium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| povidoniod 10 % vaginalgel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| povidoniod 10 % sæt til vaginalskylning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Clioquinol 10 mg/mL and flumetasone pivalate 200 microgram/mL ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Miconazole [oropharyngeal] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Natamycin [mouth-no preps] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Nystatin [mouth] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| nystatin 100.000 enheder pastil |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Benzalkonium chloride 500 microgram oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Domiphen bromide 500 microgram and lidocaine hydrochloride 5 mg oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| cetylpyridiniumchlorid 0,066 % sugetablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| cetylpyridiniumchlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| hexetidin 0,1 % mundskyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Povidone-iodine [mouth] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| povidoniod mundskyllevæske + gurglevand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Ichthammol 10% ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Zinc+ichthammol cream BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Benzoyl peroxide [acne] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Benzoyl peroxide 100 mg/g and potassium hydroxyquinoline sulfate 5 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| benzoylperoxid + kaliumhydroxyquinolinsulfat 5/0,5 % gel-lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Clindamycin [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Benzoyl peroxide [generic additions] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing precisely benzoyl peroxide 40 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Benzoyl peroxide 50 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Benzoyl peroxide 100 mg/g cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing precisely benzoyl peroxide 100 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| benzoylperoxid 2,5 % vandig gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| benzoylperoxid 5 % vandig gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| benzoylperoxid 10 % vandig gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| benzoylperoxid 10 % skyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Silver nitrate [warts] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Toughened silver nitrate BP 95% stick |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing precisely povidone iodine 40 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing precisely ketoconazole 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Benzoyl peroxide [antifungal] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing precisely benzoyl peroxide 50 milligram/1 gram and potassium hydroxyquinoline sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Econazole nitrate [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Ecostatin 1% dry powder spray 200g |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Ketoconazole [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Ketoconazole 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Miconazole nitrate [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Miconazole nitrate 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| miconazolnitrat 2 % pudder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing precisely miconazole nitrate 1.6 milligram/1 gram conventional release powder for cutaneous spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Natamycin [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Nystatin [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Nystatin 100000 unit/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
| Nystatin 100000 unit/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Some |
|
FHIR